Related references
Note: Only part of the references are listed.Emerging Role of Hydrogels in Drug Delivery Systems, Tissue Engineering and Wound Management
Shery Jacob et al.
PHARMACEUTICS (2021)
Recent advances in thermo-sensitive hydrogels for drug delivery
Yibin Yu et al.
JOURNAL OF MATERIALS CHEMISTRY B (2021)
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer
I. Ray-Coquard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Numerical modeling of high-intensity focused ultrasound-mediated intraperitoneal delivery of thermosensitive liposomal doxorubicin for cancer chemotherapy
Mohsen Rezaeian et al.
DRUG DELIVERY (2019)
Characteristics and outcomes of patients with recurrent ovarian cancer undergoing early phase immune checkpoint inhibitor clinical trials
Emily Hinchcliff et al.
GYNECOLOGIC ONCOLOGY (2018)
Bevacizumab in ovarian cancer: A critical review of phase III studies
Luigi Rossi et al.
ONCOTARGET (2017)
Tumor Infiltrative Pattern Predicts Sites of Recurrence After Curative Gastrectomy for Stages 2 and 3 Gastric Cancer
Mitsuro Kanda et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Genetic alterations and their clinical implications in gastric cancer peritoneal carcinomatosis revealed by whole-exome sequencing of malignant ascites
Byungho Lim et al.
ONCOTARGET (2016)
Worldwide burden of colorectal cancer: a review
Pasqualino Favoriti et al.
UPDATES IN SURGERY (2016)
Looking up: Recent advances in understanding and treating peritoneal carcinomatosis
Laura A. Lambert
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Updated evidence on adjuvant treatments for gastric cancer
Mitsuro Kanda et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2015)
Epigenetic modulation and repression of miR-200b by cancer-associated fibroblasts contribute to cancer invasion and peritoneal dissemination in gastric cancer
Junji Kurashige et al.
CARCINOGENESIS (2015)
Peritoneal carcinomatosis of gastric origin: A population-based study on incidence, survival and risk factors
Irene Thomassen et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Enhanced antitumor activity of different double arms polyethyleneglycol-modified liposomal doxorubicin
Ikumi Sugiyama et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Gastric cancer-molecular and clinical dimensions
Roopma Wadhwa et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Optimization of Drug Delivery Systems for Intraperitoneal Therapy to Extend the Residence Time of the Chemotherapeutic Agent
L. De Smet et al.
SCIENTIFIC WORLD JOURNAL (2013)
Phase I Trial of Intraperitoneal Pemetrexed, Cisplatin, and Paclitaxel in Optimally Debulked Ovarian Cancer
Setsuko K. Chambers et al.
CLINICAL CANCER RESEARCH (2012)
Benefit of Adjuvant Chemotherapy for Resectable Gastric Cancer A Meta-analysis
Xavier Paoletti et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial
Ilfet Songun et al.
LANCET ONCOLOGY (2010)
OncoGel (ReGel/paclitaxel) - Clinical applications for a novel paclitaxel delivery system
Nancy L. Elstad et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Phase 1 study of escalating-dose OncoGel® (ReGel®/paclitaxel) depot injection, a controlled-release formulation of paclitaxel, for local management of superficial solid tumor lesions
Svetislava J. Vukelja et al.
ANTI-CANCER DRUGS (2007)
Recent advances in the treatment of peritoneal dissemination of gastrointestinal cancers by nucleoside antimetabolites
Yutaka Yonemura et al.
CANCER SCIENCE (2007)
Intraperitoneal chemotherapy and the NCI clinical announcement
Edward L. Trimble et al.
GYNECOLOGIC ONCOLOGY (2006)
Mechanisms of transcoelomic metastasis in ovarian cancer
David S. P. Tan et al.
LANCET ONCOLOGY (2006)
Intraperitoneal cisplatin and paclitaxel in ovarian cancer
DK Armstrong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer-pooled analysis from three multicenter, randomized, controlled trials using individual patient data
I Chou et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Share Paper
